Skip to main content
. 2017 Mar 22;45(10):1319–1328. doi: 10.1111/apt.14031

Figure 4.

Figure 4

Proportions of composite responders over weeks 1–4 (month 1) who remained responders over 3 or 5 out of the subsequent 5 months: pooled analysis of Phase 3 studies. Composite response is based on daily improvement of ≥30% in worst abdominal pain score compared with average baseline pain and, on the same day, a Bristol Stool Form Scale score of <5, on ≥50% of treatment days.